Contract facts
FederalEXERCISE OPTION PERIOD 3 is a federal award for Technology Acquisition Center Nj (36C10B) held by Perspecta Enterprise Solutions LLC. Estimated value $147.2M ($39.4M obligated). Current period of performance ends Jan 3, 2024. Last award drew 2 bidders. Place of performance: HERNDON, VA.
Recompete timing
PublicCurrent PoP ended Jan 3, 2024 (961 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordPerspecta Enterprise Solutions LLC — $2.9B obligated across 395 awards (firm-wide, all agencies) · lead buyer General Services Administration (GSA).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract 36C10B19N10230005?
36C10B19N10230005 (Exercise OPTION PERIOD 3) is a Technology Acquisition Center Nj (36C10B) award with an estimated value of $147.2M, currently held by Perspecta Enterprise Solutions LLC. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
Which office awarded 36C10B19N10230005?
Technology Acquisition Center Nj (36C10B) awarded 36C10B19N10230005 to Perspecta Enterprise Solutions LLC.
Who is the incumbent on 36C10B19N10230005?
Perspecta Enterprise Solutions LLC is the incumbent with $2.9B across 395 related awards in SCOUT’s public footprint. The current period of performance ends Jan 3, 2024.
When does Perspecta Enterprise Solutions LLC’s 36C10B19N10230005 come up for recompete?
SCOUT tracks a period-of-performance end of Jan 3, 2024. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.
